Hayward-based Intarcia Therapeutics is in advanced talks for licensing agreements on its websites.

The licensing deals would be for drug technologies that go beyond its primary implant to treat diabetes.

Intarcia is meeting with as many as five pharmaceutical and biotech companies in the coming days to discuss the licensing, the company's CEO said.

The licensing efforts would center on finding treatments for pain and neurological disorders, obesity and cardiovascular disease.




Advertisement